BTIG’s Tim Chiang Appears on CNBC to Discuss the Latest Valeant News
Tim Chiang, BTIG Specialty Pharmaceuticals and Biotechnology Analyst, discusses Valeant on CNBC.
Tim Chiang, BTIG Specialty Pharmaceuticals and Biotechnology Analyst, discusses Valeant on CNBC.